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Abstract. We have examined whether the two cysteine 
residues (Cys  3° and Cys  34) in the cytoplasmic tail of the 
cation-dependent mannose 6-phosphate receptor are 
palmitoylated via thioesters and whether these residues 
influence the biologic function of the receptor, To do 
this, mouse L cells expressing wild-type and mutant re- 
ceptors were analyzed by metabolic labeling with 
[3H]palmitate, immunoprecipitation, and SDS-PAGE. 
Both Cys  3° and Cys  34 were found to be sites of palmi- 
toylation and together they accounted for the total 
palmitoylation of the receptor. The palmitate rapidly 
turned over with a half-life of ~2 h compared to a half- 
life of greater than 40 h for the protein. Mutation of 
Cys  34 to Ala resulted in the gradual accumulation of the 
receptor in dense lysosomes and the total loss of cathep- 
sin D  sorting function in the Golgi. A  Cys  3° to Ala mu- 
tation had no biologic consequences, showing the im- 
portance of Cys  34. Mutation of amino acids 35-39 to 
alanines impaired palmitoylation of Cys  3° and Cys  34 
and resulted in abnormal receptor trafficking to lyso- 
somes and loss of cathepsin D  sorting. 
These data suggest that palmitoylation of Cys  3° and 
Cys  34 leads to anchoring of this region of the cytoplas- 
mic tail to the lipid bilayer. Anchoring via Cys  34 is es- 
sential for the normal trafficking and lysosomal enzyme 
sorting function of the receptor. 
T 
HE cation-dependent mannose 6-phosphate  recep- 
tor (CD-MPR) 1 is a type I integral membrane pro- 
tein that functions to transport newly synthesized 
acid hydrolases from the trans-Golgi network (TGN) to an 
acidified endosomal (prelysosomal) compartment (Korn- 
feld and  Mellman,  1989;  Ludwig et al.,  1995;  Hille-Reh- 
reid, 1995). After discharging its ligand, the receptor either 
returns to the Golgi to repeat the process or moves to the 
plasma  membrane  where  it  is  rapidly  internalized  via 
clathrin-coated vesicles. This trafficking between the TGN, 
endosomes, and the plasma membrane is directed by sig- 
nals located in  the receptor's 67 amino acid cytoplasmic 
tail.  A  di-leucine containing sequence near the carboxyl 
terminus of the cytoplasmic tail is required for efficient en- 
try into Golgi clathrin-coated pits while two signals medi- 
ate  the  rapid  internalization  at  the  plasma  membrane 
(Johnson et al., 1990; Johnson and Kornfeld, 1992). One of 
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1. Abbreviations used in this paper: CD-MPR, cation-dependent mannose 
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ceptor, mannose 6-phosphate/insulin-like growth factor II receptor. 
these signals includes Phe 13 and Phe 18 while the second 
signal involves Tyr 45. 
Recently, we reported that the cytoplasmic tail of the 
CD-MPR contains a  third signal which functions to pre- 
vent the receptor from trafficking from endosomal com- 
partments to lysosomes (Rohrer et al., 1995). Analysis of a 
series of truncation and alanine scanning mutants impli- 
cated amino acids 34-39 of the cytoplasmic tail (CysArg- 
SerLysProArg) as being necessary for avoidance of lysoso- 
mal degradation. In addition, the transmembrane domain 
of the CD-MPR contributed to this function, Our data did 
not allow us to distinguish whether amino acids 34-39 con- 
stituted part or all of this signal or if these amino acids de- 
termined  a  critical  conformation of the  cytoplasmic tail 
that is required for the expression of a sorting signal lo- 
cated elsewhere in the cytoplasmic tail. 
The cytoplasmic tail of the CD-MPR contains two cys- 
teine residues which  are located at  positions 30  and  34. 
Thus Cys  34 is part of the amino acid sequence that is neces- 
sary  to  prevent  receptor  trafficking  to  lysosomes  while 
Cys  3° is located close to this critical region. When a con- 
struct  (MPR  C30C34A)  containing  alanine  residues  in 
place of Cys  30 and Cys  34 was  expressed in mouse L  cells, 
the mutant receptor was found to accumulate in dense ly- 
sosomes to the same extent as a receptor with amino acids 
34-39 changed to alanines (MPR 34-39A) (Rohrer et al., 
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were involved in preventing the receptor from trafficking 
to lysosomes. 
In  the present study, we  demonstrate that  both  Cys  3° 
and Cys  34 are reversibly palmitoylated and that the extent 
of palmitoylation is influenced by amino acids 35-39 of the 
cytoplasmic tail. A mutant receptor with Cys  34 changed to 
Ala (MPR C34A) has the same phenotype as the MPR 34- 
39A construct whereas a  receptor with Cys  3° mutated to 
Ala  (MPR  C30A)  behaves  like  the  wild-type  receptor. 
Further,  we  show  that  MPR  C34A,  MPR  34-39A  and 
MPR 35-39A, are greatly impaired in their ability to sort 
cathepsin D  in the Golgi, implying that mutations in this 
region of the cytoplasmic tail have generalized effects on 
receptor function. 
Materials and Methods 
Materials 
Enzymes used in molecular cloning were obtained from Boehringer Mann- 
helm Biochemicals (Indianapolis,  IN),  New  England Biolabs (Beverly, 
MA),  or Promega Corp.  (Madison, WI); ct-MEM,  FCS,  and lipofectin 
were from GIBCO BRL (Gaithersburg, MD); PercoU from Pharmacia Di- 
agnostics AB (Uppsala, Sweden); [3H]Palmitate, Amplify, and enhanced 
chemiluminescence Western  blotting  reagents  from  Amersham Corp. 
(Arlington  Heights, IL);  Expre35S35S label  from New England Nuclear 
(DuPont Co., Wilmington, DE); protein A-Sepharose beads from Repli- 
gen Corp. (Cambridge, MA); rabbit anti-mouse IgG from Zymed Labo- 
ratories,  Inc.  (San Francisco,  CA); protease  inhibitors, hydroxylamine, 
and palmitate from Sigma Chem. Co. (St. Louis, MO), nitrocellulose from 
Schleicher and Schuell, Inc.  (Keene, NH);  and cell culture dishes from 
Falcon Labware (Becton Dickinson Co., Lincoln Park, N J). 
Oligonucleotides  were  synthesized  with  a  solid  phase  synthesizer 
(380A; Applied Biosystems, Inc., Foster City, CA) by the Protein Chemis- 
try Facility of Washington University. 
Recombinant DNA 
All basic DNA procedures were as described (Sambrook et al., 1989). 
The PCR procedure of Ho et al. (1989) was used to generate the MPR 
C30A and MPR C34A constructs with pBSK-MPR  T~n/tail (Rohrer et al., 
1995)  serving as a  template together with bp  170-193  and 1260-1241  of 
pBSK as the down- and upstream primers. Appropriate partial comple- 
mentary pairs of oligonucleotides in which the desired alanine replace- 
ment had been incorporated were chosen as internal primers. The final 
PCR products were digested with BglII and MluI, and the purified frag- 
ments were assembled with the EcoRI-BglII fragment of pBSK (B-H-)- 
MPR (BglII-)  (Rohrer  et al.,  1995)  and the EcoRI-MluI fragment of 
pSFFVneo in a three part ligation. 
The generation of all other constructs used in this study has been de- 
scribed previously (Rohrer et al., 1995). 
Cell Culture and Transfection 
A  Man-6-P/IGF-II  receptor-deficient  mouse L  cell  line  designated D9 
(LRec-) was maintained in ct-MEM containing 10% heat-inactivated FCS, 
100 U/ml penicillin, and 100 Ixg/ml streptomycin at 37°C in a 5% humidi- 
fied CO2 atmosphere (Gabel et al., 1983). The cells were transfected with 
20 Ixg of XbaI-linearized DNA using lipofectin (GIBCO BRL) according 
to  the  manufacturer's directions.  Selection  for  resistance to  neomycin 
(G418) was as described previously (Rohrer et al., 1995).  Resistant colo- 
nies  were  screened  for expression by immunoblotting. Selected  clones 
were expanded for further study and maintained in selective medium. 
Antibodies 
mAb 22D4 specific for the bovine CD-MPR has been described (Messner, 
1993).  For the detection of cathepsin D, rabbit anti-human cathepsin D 
antiserum (provided by Walter Gregory of this laboratory) (Johnson and 
Kornfeld, 1992; Faust et al., 1987) was used. 
Metabolic Labeling with [3H]Palmitate and 
[35S]MethioninelCysteine 
Cells were grown in 60-ram dishes. For labeling with [3H]palmitate, the 
cells were washed twice with serum-free ct-MEM and labeled in 1.5 ml 
ct-MEM  containing 5%  FCS,  20  mM Hepes,  pH  7.4,  and  600  ~Ci  of 
[3H]palmitate for 3 h  at 37°C.  For labeling with [35S]methionine/cysteine, 
the cells were rinsed twice with PBS, preincubated in 1.5 ml of methio- 
nine- and cysteine-free growth medium containing 10% dialyzed FCS and 
20 mM Hepes, pH 7.4, for 20 rain, and pulsed for 3  h  with  150  IxCi of 
Expre35S35S protein labeling mixture in 1.5 ml of preincubation medium. 
For pulse chase experiments cells were labeled with [3H]palmitate for 90 
min at 37°C as described above, and then chased in 2 ml of normal culture 
medium supplemented with 20 mM Hepes, pH 7.4, and 100 ~,M unlabeled 
palmitic acid for 0-12 h. Proteins were immunoprecipitated from Triton 
X-100-solubilized cells as described in Rohrer et al. (1995). The immuno- 
complexes were released from the beads by boiling for 3 rain in electro- 
phoresis sample buffer containing 62.5 mM Tris-HC1, pH 6.8,  2%  SDS, 
10% glycerol, and 0.001% bromophenol blue. 
Hydroxylamine Treatment 
CD-MPR protein labeled with [3H]palmitate or [35S]methionine/cysteine 
was electrophoresed in duplicate lanes on 10% SDS-polyacrylamide gels. 
The gels were fixed with 25% methanol, 10% acidic acid for 90 min, and 
subsequently rinsed in water three times for 10 min to remove the acidic 
acid. One gel was treated for 14 h  with 1.0 M  Tris, pH 7.0,  as a control 
while the other gel was soaked for 14 h in 1.0 M  hydroxylamine, pH 7.0. 
The gels were then rinsed in water and prepared for fluorography. 
PercoU Gradient Fractionation 
Confluent cells grown in a  100-mm petri dish were incubated for 24 h  in 
growth medium supplemented with 100 ixM each of pepstatin A  and leu- 
peptin. After two washes with PBS, the cells were scraped into 2 ml of ho- 
mogenization buffer (HB)  (0.25  M  sucrose, i  mM EDTA, pH 7.5) and 
centrifuged for 10 rain at 140 g. The cells were resuspended in 850 ~1 of 
HB, and passed 12 times through a ball-bearing homogenizer (Balch and 
Rothman, 1985) with a clearance of 51.2 ~m. The homogenate was diluted 
with an additional 850 p~l HB and centrifuged for 10 min at 400 g. The re- 
suiting postnuclear supernatant was layered over a discontinuous gradient 
consisting of a 1.2-ml cushion of 10 x  HB and 8.5 ml of an 18% Percoll so- 
lution in 1 ×  HB. The gradient was centrifuged for 30 min at 20,000 rpm in 
a Ti 50 rotor (Beckman Instruments Inc., Palo Alto, CA). The cushion fol- 
lowed by nine fractions of 1.2 ml were collected from the bottom of the tube. 
The gradient fractions were then combined as follows: fractions 1-3 (pool I, 
containing 70-80% of lysosomal enzyme activity), fractions 4--6 (pool II, con- 
taining intermediate density membranes), and fractions 7-9 (pool llI, con- 
taining low density membranes including endosomes, the Golgi complex, 
plasma membranes, and the endoplasmic reticulum). The Percoll was re- 
moved by centrifugation twice for 30 rain at 85,000 rpm in a TL 100.3 rotor 
(Beckman Instruments Inc.). The pelleted membranes were  transferred 
into 1.5-ml ultracentrifugation tubes, diluted with HB to a final volume of 
1 ml and centrifuged for an additional 50 rain at 70,000 rpm in the TL 
100.3 rotor to remove the remaining Percoll. The sedimented membranes 
were transferred into 1.5-ml tubes and mixed with HB to a final volume of 
300  p.l. The samples were  adjusted to  0.5%  TX-100,  passed five times 
through a 25-gauge needle connected to a 1-ml syringe, and solubilized on 
ice for 30 min. An aliquot corresponding to 1:10 of the total volume was 
removed for the 13-hexosaminidase assay. 300 p~l of 3× nonreducing elec- 
trophoresis sample buffer was added to  the remaining sample and the 
mixture was boiled for 3 rain. Aliquots corresponding to 1:15 of the final 
sample volume were analyzed by SDS-PAGE and immunoblotting. 
Cathepsin D Sorting Assay 
Confluent ceil monolayers in 6-well tissue culture dishes were labeled for 
30 min at 37°C with 300 p.Ci of Expre35sass protein labeling mixture in a 
total volume of 1 ml as described above, and then chased in i ml of normal 
culture medium in the presence of 10 mM unlabeled methionine and 20 
mM Hepes, pH 7.4, for 4 h. At the end of the chase, the efficiency of sort- 
ing was  determined by  immunoprecipitating the  cellular  and  secreted 
cathepsin D. The media were clarified by centrifugation at 20,000 rpm for 
30 min in a JA-20 rotor. The cells were chilled on ice, washed twice with 2 
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min at 140 g. The resulting pellets were resuspended in 1 ml of homogeni- 
zation buffer (PBS, containing 10 mM EDTA, 0.5% Triton X-100, and a 
1:500 dilution of a protease inhibitor cocktail [5 rag/m1 benzamidine, and 1 
~g/ml of pepstatin A, leupeptin, antipain, and chymostatin in 40% dimeth- 
ylsulfoxide-60% ethanol]), passed five times through a  25-gauge needle 
connected to a 1-ml syringe, and then sonicated on ice for 10 s at 120 W 
with a probe sonicator. After incubating for 30 min on ice, the cell lysates 
were centrifuged for 60 rain at 39,000 rpm in a Ti50 rotor. The cell and me- 
dia high speed supernatants were then adjusted to 0.1 M Tris-HCl, pH 8.0, 
0.1 M KCI, 5 mM MgClz, 1% Triton X-100, 0.5% Na deoxycholate, 0.3% 
SDS, 40  ixg/ml phenylmethylsulfonyl fluoride and  1×  of the above de- 
scribed protein inhibitor cocktail. Rabbit antiserum to cathepsin D  was 
added, and the samples were incubated overnight at 4°C with constant 
mixing. 25 p,l of protein A-Sepharose beads was added, and the incuba- 
tion continued for another 2  h  at 4°C.  The protein A-Sepharose beads 
were pelleted, washed four times with I ml 0.1 M Tris-HC1,  pH 8.0, 0.1 M 
NaC1, 1% Triton X-100, and twice with 1 ml 0.1 M Tris-HCl, pH 8.0. Im- 
munoprecipitates were eluted by boiling for 3 min in nonreducing SDS 
sample buffer as described above. 
SDS-PA  GE, Fluorography, and Immunoblotting 
Proteins were separated on 10%  SDS-polyacrylamide minigels (BioRad 
Laboratories)  using the Laemmli (1970)  system. After electrophoresis, 
gels were either treated with Amplify, dried, and exposed to film (XOmat 
AR; Eastman  Kodak  Co.,  Rochester, NY)  (metabolic labeling experi- 
ments;  cathepsin  D  sorting  assays)  or  transferred onto  nitrocellulose 
membranes according to the method of Towbin et al. (1979)  (Percoll den- 
sity fractionation). The nitrocellulose sheet was blocked with 3% nonfat 
dry milk powder (Schnuck Markets, Inc., St. Louis, MO) in PBS. The blot 
was subsequently incubated with mAb 22D4  (diluted  1:500 in PBS-3% 
powdered milk) followed by HRP-conjugated anti-mouse secondary anti- 
body (Amersham Corp.). Immunoreactive proteins were visualized using 
the enhanced chemiluminescence detection system according to the man- 
ufacturer's directions. The fluoro- and autoradiographs were quantitated us- 
ing a Personal Densitometer (Molecular Dynamics, Inc., Sunnyvale, CA). 
Assays and Miscellaneous  Methods 
13-Hexosaminidase activity was determined as described (Rohrer et al., 
1995). Protein was determined with the BioRad (Richmond, CA) protein 
assay kit using protein standard I, or with the Micro BCA protein assay 
(Pierce, Rockford, IL). 
Results 
CD-MPR Is Reversibly Palmitoylated 
Since a mutant CD-MPR containing alanines at positions 
30 and 34 of the cytoplasmic tail instead of the normal cys- 
teines accumulated in dense lysosomes, we were interested 
in determining whether the cysteines were palmitoylated 
under normal conditions. To do this, a mouse L  cell line 
(ML4)  stably expressing the  wild-type bovine CD-MPR 
was labeled with either [3H]palmitate or [35S]methionine/ 
cysteine for 3 h. The expressed CD-MPR was then immu- 
noprecipitated and subjected to SDS-PAGE. As shown in 
Fig. 1, the receptor incorporated both labels. As expected 
for a thioester linkage (Schlessinger et al., 1980; Kaufman 
et  al.,  1984),  the  3H  label  bound  to  the  CD-MPR  was 
mostly released by treatment with hydroxylamine at neu- 
tral  pH  (lane  2).  This  treatment  had  no  effect on  the 
amount of [35S]methionine/cysteine incorporated into the 
protein (lane 4). It is also apparent from Fig. I that there is no 
[3H]palmitate incorporated in the "ER-form" of the CD- 
MPR  (the  lower molecular weight band in  the  [35S]me- 
thionine/cysteine lane). This is an indication that the palmo 
itate is added in a late-Golgi or post-Golgi compartment. 
Figure L  [3H]Palmitate label- 
ing of CD-MPR. Mouse L cells 
stably expressing wt CD-MPR 
were labeled  with [3H]palm- 
itate  or  [35S]methionine/ 
cysteine  for 3  h.  Duplicate 
samples of CD-MPR immuno- 
precipitates  were  separated 
on 10% SDS polyacrylamide 
gels.  One  gel  was  subse- 
quently soaked for 14 h in 1 M 
Tris,  pH  7.0, as  a  control, 
whereas  the  other  gel  was 
treated  for  14  h  with  1  M 
NH2OH, pH 7.0, followed by 
fluorography.  The  upper 
band  at  ,'-~90 kD  is  the 
dimeric form of the receptor. The numbers at the left margin of 
the gel indicate the migration of molecular mass standards in ki- 
lodaltons. 
When the MIA cells were labeled with [3H]palmitate for 
90 min and chased for up to 12 h followed by immunopre- 
cipitation of the CD-MPR and SDS-PAGE, it was appar- 
ent that the covalently bound  [3H]palmitate was rapidly 
turning over (Fig. 2). A plot of these data gave rise to a bi- 
phasic curve, with the initial "rt/2  being ~2 h followed by a 
second, slower decay (~1/2 of ~20 h). The second phase of 
the curve is most likely the result of reutilization of the 
[3H]palmitate (Magee et al., 1987; Staufenbiel, 1987). The 
'rl/2 of 2 h is much shorter than the TI/2 of the protein (>40 
h)  as  determined  by  [35S]methionine/cysteine  labeling 
(Fig. 2 B). These data establish that the CD-MPR is re- 
versibly palmitoylated. 
Cys  3° and Cys  34 Are the Sites of Palmitoylation 
in CD-MPR 
Cys  3° and Cys  34 are the only cysteines in the 67-amino acid 
cytoplasmic tail of the CD-MPR and none are present in 
the  transmembrane  domain  (Fig.  3 A).  Thus,  Cys  30  and 
Cys  34 were the likely candidates to undergo palmitoylation 
via thioester linkages (Sefton and Buss, 1987).  To pursue 
this, three constructs were analyzed. One construct (MPR 
C30C34A)  had both cysteines changed to alanines while 
the  other two constructs  (MPR  C30A  and  MPR  C34A) 
had either one or the other cysteine mutated to alanine. 
Cells expressing these mutant receptors were labeled with 
[3H]palmitate and analyzed as before. As shown in Fig. 3 
B, there was no detectable incorporation of [3H]palmitate 
into  MPR  C30C34A  while  both  MPR  C30A  and  MPR 
C34A  were labeled.  When  the  [3H]palmitate incorpora- 
tion was expressed as a function of receptor content, as de- 
termined by quantitative  Western  blotting  (Fig.  3  C),  it 
could be calculated that MPR C30C34A, MPR C30A, and 
MPR C34A contained 0, 90, and 56% as much [3H]palmi- 
tate as the wild-type receptor (Fig. 3 D). 
These data demonstrate that both Cys  3° and Cys  34 are 
palmitoylated and together they account for all the palmi- 
toylation that occurs in the CD-MPR. The loss of palmi- 
toylation at Cys  3° appears to be compensated by increased 
palmitoylation at Cys  34. 
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L  cells  stably  expressing  wt  CD-MPR  were  labeled  with 
[3H]palmitate and chased for the indicated time intervals. CD- 
MPR was  then immunoprecipitated with mAb 22D4  and  ana- 
lyzed by SDS-PAGE (10% gel). (B) The fluorograph shown in A 
and those from additional experiments were quantitiated by scan- 
ning densitometry. At each time point the amount of [3H]palmi- 
toylated receptor (O) detected is plotted as the percentage of the 
value obtained at the 0-h chase point. The turnover rate of [35S] 
methionine-labeled CD-MPR (A) is shown for comparison (Roh- 
rer et al., 1995). 
Effect of the Amino Acids Surrounding Cys  z° 
4  and Cys  3  on Palmitoylation 
We next tested whether  the  amino acids near the palmi- 
toylation sites influenced the  extent of this modification. 
For this purpose, we used a  series of constructs in which 
amino acids 28-50 of the cytoplasmic tail were substituted 
with stretches of alanines. The results are summarized in 
Fig. 4. MPR 28-33A was palmitoylated 65%  as well as the 
wild-type CD-MPR,  somewhat  less  than  the  90%  value 
obtained with MPR C30A. Thus the residues surrounding 
Cys  3° do not influence palmitoylation in a  major way. By 
contrast, MPR 34-39A was only palmitoylated to 10%  the 
level of the wild-type receptor, compared to 56% for MPR 
C34A. This suggests that amino acid residues 35-39 of the 
cytoplasmic tail are required  for  optimal palmitoylation. 
Consistent with this notion was the finding that MPR 35- 
39A was only palmitoylated 42%  as well as the wild-type 
receptor in spite of containing both Cys  3° and Cys  34. MPR 
40=45A and MPR 46-50A were palmitoylated to about the 
Figure 3.  Cys  3° and Cys  34 in the cytoplasmic tail of CD-MPR are 
palmitoylated. (A) Schematic illustration of the cytoplasmic tail 
of CD-MPR. Selected amino acids of the tail are shown; the half 
box represents the terminus of the single transmembrane domain 
of CD-MPR.  (B) Mouse L cells stably expressing wt CD-MPR, 
MPR C30C34A, MPR C30A, and MPR C34A were labeled with 
[3H]palmitate.  CD-MPR  was  immunoprecipitated  with  mAb 
22D4 and analyzed by SDS-PAGE (10% gel). For each sample 
the total amount of protein subjected to immunoprecipitation is 
shown underneath  the fluorograph. (C) Level of CD-MPR ex- 
pression in the individual transfected cell lines. 20 ~g of protein 
from the cell homogenates from duplicate plates to the ones la- 
beled  with  [3H]palmitate  were  subjected  to  SDS-PAGE  and 
Western blotting with mAb 22D4.  (D) Quantitation of [3H]palm- 
itate incorporation into  CD-MPR  cysteine mutants.  The  fluo- 
rograph and the immunoblot shown in B and C, respectively, and 
those from additional experiments were quantitated by densito- 
metric scanning. In each experiment the values obtained for the 
[3H]palmitate  incorporation  were  corrected  for  the  different 
amounts  of protein used for immunoprecipitation, and for the 
differences in expression levels. The value obtained with the CD- 
MPR was set to 100%. 
same extent as the wild-type receptor indicating that these 
residues do not influence palmitoylation. 
MPR C34A, but Not MPR C30A, Accumulates in 
Dense Lysosomes 
In our previous study, we demonstrated that MPR C30C34A 
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MPR alanine  scanning mutants.  Mouse L cells stably expressing 
CD-MPR, MPR 28-33A, MPR 34-39A, MPR 40-45A, MPR 46- 
50A, MPR 35-39A, MPR 34-36A, and MPR 37-39A were labeled 
with [3H]palmitate. CD-MPR was immunoprecipitated with mAb 
22D4 and analyzed by SDS-PAGE. The quantitation of several 
experiments is shown. The values were calculated as described in 
Fig. 3. 
accumulates in dense lysosomes whereas the wild-type re- 
ceptor  is  excluded  from  that  organelle  (Rohrer  et  al., 
1995).  It was therefore of interest to determine whether 
MPR C30A and MPR C34A, which have only one cysteine 
mutated,  retain  the  ability  to  avoid  trafficking  to  lyso- 
somes. For this purpose, cell lines expressing these mutant 
receptors were first preincubated for 24 h in the presence 
of pepstatin A  and leupeptin in order to inhibit degrada- 
tion  of receptors  that  had  entered  lysosomes. The  cells 
were then harvested, homogenized with a ball-bearing ho- 
mogenizer, and subjected to Percoll density gradient cen- 
trifugation.  Under these conditions,  dense lysosomes are 
recovered at the bottom of the gradient (pool I) whereas 
low density membranes including  endosomes,  the  Golgi 
complex, plasma membranes, and the endoplasmic reticu- 
lum are found near the top of the gradient (pool III). In- 
termediate  density  membranes  are  recovered in  pool  II 
(Green et al., 1987). 
The  distribution  of  the  various  receptors  was  deter- 
mined by electrophoresis of the Percoll density fractions 
followed by Western blotting (Fig. 5, A and B for quantita- 
tion).  As  reported  previously, the  CD-MPR  was  almost 
completely excluded from dense lysosomes (4% recovered 
in pool I) whereas 30% of MPR C30C34A was recovered 
in pool I  (Rohrer et al.,  1995).  MPR  C30A behaved the 
same  as  the  wild-type  receptor  (4%  in  pool  I) whereas 
MPR  C34A  had  a  distribution  similar  to  that  of  MPR 
C30C34A (26% in pool I). These data indicate that Cys  34 
is essential for avoiding receptor trafficking to dense lyso- 
somes while Cys  3° is not sufficient to prevent the receptor 
from entering this organelle. 
Mutation of Cys  34 of the Cytoplasmic Tail Abolishes the 
Cathepsin D Sorting Function 
We next tested whether mutation of Cys  3° and Cys  34 altered 
Figure 5.  Subcellular distribution  of MPR C30A and MPR C34A 
on Percoll gradients.  (A) Mouse L cells stably expressing wt CD- 
MPR, MPR C30A, and MPR C34A were preincubated with pep- 
statin A and leupeptin for 24 h. Cells were homogenized with a 
ball-bearing  homogenizer  and  postnuclear  supernatants  were 
subjected to Percoll  density  gradient centrifugation  (18%  Per- 
coil) as described  in Materials  and Methods.  Proteins of pool I 
(dense lysosomes), pool II (intermediate membranes), and pool 
III (low density membranes) were subjected  to SDS-PAGE and 
immunoblotting with mAb 22D4. (B) Quantitation of the immu- 
noblots shown in A and those from additional  experiments.  For 
each construct,  the value of pool I (dense lysosomes, filled bars) 
and the values of pool II and III combined (striated bars) were 
expressed as their percentage of the total value of all three pools. 
The distributions  of wt CD-MPR and MPR C30C34A from Roh- 
rer et al. (1995) are shown for comparison. 
the  ability  of the  receptor  to  sort  cathepsin  D  to  lyso- 
somes. This function requires the receptor to recycle to the 
Golgi where  it  must  bind  cathepsin  D  and  enter  Golgi 
clathrin-coated  vesicles  which  transport  the  receptor- 
ligand complex to endosomal compartments. Cells express- 
ing  the  various  receptors  were  incubated  with  [35S]me- 
thionine/cysteine  for 30 min  and chased for 4  h  to allow 
the newly synthesized cathepsin D  to be phosphorylated 
and  either targeted to lysosomes or secreted. Equivalent 
aliquots of cell homogenates and media were immunopre- 
cipitated  and  the  immunoprecipitates  were  analyzed  by 
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lar form of cathepsin D  migrates faster than the secreted 
form because of proteolytic processing of the proform to 
give rise to the mature species. This processing indicates 
that the cathepsin D  has reached the lysosomes. The re- 
suits of these and additional sorting assays are summarized 
in Table I. The D9 cell line which expresses only endoge- 
nous mouse CD-MPR sorted 25 __- 6% of the newly syn- 
thesized cathepsin D  to lysosomes ("basal level") and se- 
creted the rest into the media. In contrast, the ML4 cell 
line  which  expresses  the  wild-type  bovine  CD-MPR, 
sorted 51 _  8% of this acid protease to lysosomes whereas 
Cc2  cells,  which  express  the  Man-6-P/IGF-II  receptor, 
sorted the cathepsin D  very efficiently (87 __+ 3%). These 
values are similar to those reported previously (Johnson 
and Kornfeld, 1992). As shown in Table I, MPR C34A and 
MPR C30C34A sorted cathepsin D at the basal level (29 _ 
3%  and  25  _+  5%,  respectively)  whereas  MPR  C30A 
sorted 48  +__ 4%  of cathepsin D, similar to the value ob- 
tained with the wild-type CD-MPR.  Thus, it is  apparent 
that mutation of Cys  34, but not Cys  3°, abolishes sorting. 
Table I  also summarizes the results obtained with the 
alanine scanning mutants.  Cells expressing MPR 34-39A 
and MPR 35-39A sorted cathepsin D at the basal level (22 ___ 
6% and 21  +_ 6%, respectively) while MPR40-45A sorted 
at  an  intermediate  level  (37  ---  1%)  and  MPR46-50A 
sorted almost as well as the wild-type receptor (44 ___ 4%). 
As shown in Table I, each of the mutant receptors that was 
defective in sorting cathepsin D had a steady-state level of 
expression comparable to that of the wild-type CD-MPR. 
Therefore the inability of these mutant receptors to sort 
cathepsin D is not due to a lack of sufficient receptor mol- 
ecules. These results indicate that amino acid residues 34- 
39 of the cytoplasmic tail of the CD-MPR influence the ly- 
sosomal enzyme sorting function. 
Discussion 
The results presented in this paper demonstrate that both 
Cys  3° and Cys 34 of the cytoplasmic tail of the CD-MPR are 
Figure 6.  Sorting of Cathepsin  D by L cells expressing mutant 
CD-MPRs. D9 cells and D9 ceils stably expressing wt CD-MPR 
(ML4), MPR C30C34A, MPR C30A, and MPR C34A were incu- 
bated with [35S]methionine/cysteine  for 30 min and chased for 4 h. 
The amount of cathepsin D sorted was determined by immuno- 
precipitating cell detergent extracts (C) and media high speed su- 
pernatants  (M) with antisera  against cathepsin  D, followed by 
SDS-PAGE and fluorography. The positions of the unprocessed 
procathepsin  D (ProCD) and the proteolytically processed ma- 
ture cathepsin D (CD) are indicated. 
Table L Sorting of Cathepsin D by L Cells Expressing Mutant 
CD-MRPs 
CD-MPR 
Ceil line  expression*  Cathepsin D sorted  * 
% 
D9  ~  25 _+ 6  (n =  8) 
Cc2  u  87 -  3  (n =  6) 
ML4!  1  51 -  8  (n =  7) 
MPR C30C34A  0.8  25 _  5  (n  =  5) 
MPR C30A  1.1  48 -4- 4  (n =  7) 
MPR C34A  1,2  29 ~  3  (n =  8) 
MPR 34-39A  1.4  22 -  6  (n =  5) 
MPR 35-39A  1.0  21 -  6  (n =  8) 
MPR 40--45A  1.1  37 -+  I  (n  =  3) 
MPR 46-50A  0.5  44 -Z-_  4  (n =  3) 
Cells were labeled with [35S]methioninedcysteine  for 30 min, chased for 4 h, and then 
further analyzed as described in Fig 6. 
*Levels of CD-MPR expression in the individual transfected cell lines are expressed 
relative to the ML4 cell line. The ML4 cell line contains 0.44 ng of CD-MPR/I~g  of 
membrane protein as determined by Johnson and Komfeld (1992). 
*Values are expressed as mean -  SE; n is the number of determinations. 
~Parental cell line, deficient in the Man-6-P/IGF-II receptor. 
IID9 cells stably expressing wt Man-6-P/IGF-II receptor. 
I D9 cells stably expressing wt CD-MPR. 
palmitoylated in a  reversible manner and that Cys  34, but 
not Cys  3°, is required for proper trafficking and lysosomal 
enzyme sorting.  Several aspects  of the palmitoylation of 
the CD-MPR are of particular interest. Among the trans- 
membrane proteins known to acquire this covalent modifi- 
cation, the palmitoylation sites are either localized within 
the transmembrane domain of the polypeptide or in the 
cytoplasmic  tail  relatively  close  to  the  transmembrane 
junctions. For instance, the transferrin receptor (Jing and 
Trowbridge, 1987, 1990) and the cell surface glycoprotein 
CD4  (Crise  and  Rose,  1992)  contain palmitoylated cys- 
teines in their transmembrane domains. CD4 has a second 
palmitoylation site located one amino acid from the trans- 
membrane domain whereas this distance is two amino acids 
in the HLA-D-associated invariant chain (Koch and Hiim- 
merling, 1986), six amino acids in vesicular stomatitis virus 
G protein (Rose et al., 1984), some subtypes of influenza 
virus hemagglutinin (Veit et al., 1991), and p63 (Schweizer 
et al., 1995), between 11 and 13 amino acids in f32-adrener- 
gic receptor (O'Dowd et al., 1989), bovine opsin (Karnik 
et al.,  1993),  and bovine rhodopsin (O'Brien et al., 1987; 
Ovchinnikov et al., 1988; Papac et al., 1992) and 15-16 amino 
acids in the luteinizing hormone/human choriogonadotro- 
pin receptor (Kawate and Menon,  1994).  The finding of 
palmitoylated  cysteines  located  29  and  33  amino  acids 
from the transmembrane domain of the CD-MPR expands 
the possibilities for this covalent modification, and has in- 
teresting implications for the structure of the cytoplasmic 
tail of this receptor. 
Since palmitoylation has been shown to enhance mem- 
brane binding of some forms of p21N-ras (Hancock et al., 
1989), the neuronal growth cone protein GAP (Skene and 
Virag, 1989; Zuber et al., 1989; Liu et al.,  1993),  and Gsa 
(Wedegaertner  et  al.,  1993),  it  seems  reasonable  that 
palmitoylation of Cys  3° and Cys  34 may anchor this portion 
of the cytoplasmic tail of CD-MPR to the lipid bilayer. As 
depicted in the model shown in Fig. 7, this could have dra- 
matic effects on the conformation of the cytoplasmic tail. 
For instance, one consequence would be to bring the Tyr  45 
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toylated Cys  3° and Cys  34 may be anchored to the lipid  bilayer, 
thereby generating an intracellular loop consisting of residues 1-30 
of the cytoplasmic tail. The residues on the carboxyl side of Cys  34 
would be brought closer to the membrane. The three basic resi- 
dues adjacent to Cys  34 could potentially interact with the acidic 
phospholipid head groups of the lipid bilayer. 
containing internalization  signal closer to the membrane. 
This signal, located 11 amino acids from Cys  34 would now 
have a spacing from the membrane that is similar to that of 
the Phe13-Phe 18 containing internalization signal. The pre- 
cise  spacing of this  signal from the  membrane could,  in 
turn, be an important determinant of its biologic activity. 
Similarly, the anchoring of the palmitoylated cysteines to 
the  membrane  could  influence  the  presentation  of  the 
Phe-containing  signal and the  di-leucine signal. Three of 
the five residues on the carboxyl side of Cys  34 (Arg  35 Ser  36 
Lys  37 Pro  38 mrg  39) have positive charges and could poten- 
tially interact with the acidic phospholipid head groups of 
the lipid bilayer, resulting in additional conformational ef- 
fects on the cytoplasmic tail. This may explain why muta- 
tion of these residues to alanines (MPR 35-39A) results in 
a 58% decrease in palmitoylation of Cys  3° and  Cys  34. The 
basic residues may serve to position this portion of the cy- 
toplasmic  tail  in  a  manner  that  is  either  favorable  for 
palmitoyltransferase to act on Cys  3° and Cys  34 or unfavor- 
able for the palmitoylesterase(s) to function. 
A  striking finding is the fact that the palmitate is rapidly 
turning over in the CD-MPR, with the "rl/2 being on the or- 
der of 2 h whereas the protein ~1/2 is greater than 40 h. It is 
well documented that palmitoylation can be either a stable 
or  reversible  modification,  although  the  actual  ~1/2 for 
palmitate turnover has only been determined in a few in- 
stances (Omary and Trowbridge, 1981; Magee et al., 1987; 
Staufenbiel,  1987).  Since mutation of Cys  34 to an alanine 
impairs  several functions  of the  receptor,  an  interesting 
possibility is that the reversible palmitoylation of this resi- 
due serves to modulate various signals in the cytoplasmic 
tail.  Perhaps palmitoylation occurs at one station during 
the trafficking of the receptor to enhance or inhibit the ac- 
tivity of a  particular signal while depalmitoylation occurs 
at another station, giving rise to the opposite effect. In this 
regard, it seems highly likely that the wild-type CD-MPR 
is incompletely palmitoylated at steady state. If palmitoy- 
lation were complete, then deletion of one of the two cys- 
teines in the cytoplasmic tail would result in a 50% drop in 
palmitate incorporation rather than the 10% decrease ob- 
served with MPR C30A. 
Receptor molecules carrying the Cys  34 to Ala mutation 
have several altered biologic properties. One is a modifica- 
tion in receptor trafficking resulting in the gradual accu- 
mulation of the mutant receptor in dense lysosomes. We 
have  suggested  that  the  cytoplasmic tail  of the  receptor 
contains  a  sorting  determinant  that  prevents delivery of 
the receptor to lysosomes (Rohrer et al., 1995).  Cys  34 or its 
palmitoylated form could be  a  component of this  signal 
along with amino acids 35-39, or else determine a critical 
conformation of the  cytoplasmic tail that  is required  for 
the expression of a sorting signal located elsewhere in the 
cytoplasmic tail. The other alteration in the function of the 
receptor with the Cys  34 to Ala mutation is the loss of abil- 
ity to  sort  newly synthesized  cathepsin  D  to  lysosomes. 
This defect in  the  sorting function could arise in several 
ways. One possibility is that the mutation impairs the recy- 
cling of the receptor to the Golgi where the binding of the 
cathepsin D  occurs. This would be consistent with the ab- 
normal trafficking of the mutant receptor from endosomes 
to lysosomes. Alternatively, the mutant receptor could re- 
turn to the Golgi and either fail to bind cathepsin D  or not 
enter the Golgi clathrin-coated vesicles after binding this 
ligand.  If the  latter  occurred,  the  CD-MPR-ligand  com- 
plex  would  travel  to  the  cell  surface  where  the  ligand 
would  probably  be  discharged  since  the  CD-MPR  is 
known to bind ligands extremely poorly at the cell surface 
(Stein et al., 1987; Ma et al., 1991).  Regardless of the par- 
ticular site of the  defect, it is striking that the change of 
this single amino acid totally abrogates this sorting func- 
tion whereas mutation of Cys  3° to Ala has no effect on ei- 
ther  cathepsin  D  sorting  or receptor trafficking to  lyso- 
somes. 
The  Man-6-P/IGF-II  receptor  contains  a  highly  con- 
served CysCysArgArg sequence at positions 15 to 18 of its 
cytoplasmic tail. Westcott and Rome (1988) reported that 
this receptor contains covalently bound fatty acid and we 
have  found  that  the  receptor  is  palmitoylated  via  a 
thioester  linkage  (Schweizer,  A.,  and  J.  Rohrer,  unpub- 
lished  data).  It will be of considerable  interest  to  deter- 
mine whether palmitoylation of this receptor influences its 
trafficking and function in lysosomal enzyme sorting. 
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